Dr. Sacks is a co-author on four poster presentations at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes Research) being held in Boston May 7-10. Three of these presentations report analyses of healthcare resource use, costs to payers, and mortality in rare and ultra-rare diseases (adrenomyelonueropathy [AMN] and non-cystic fibrosis bronchiectasis [NCFB]). Another looks at healthcare resource use and costs associated with oral antibiotic treatment failure in patients treated for uncomplicated urinary tract infection (UTI) in the US. If you are at ISPOR, reach out to Naomi!
